Blood-based biomarkers in breast cancer: From proteins to circulating tumor cells to circulating tumor DNA
出版年份 2018 全文链接
标题
Blood-based biomarkers in breast cancer: From proteins to circulating tumor cells to circulating tumor DNA
作者
关键词
-
出版物
TUMOR BIOLOGY
Volume 40, Issue 5, Pages 101042831877616
出版商
SAGE Publications
发表日期
2018-05-18
DOI
10.1177/1010428318776169
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- A review of the value of human epidermal growth factor receptor 2 (HER2)-targeted therapies in breast cancer
- (2018) N.A. Nixon et al. EUROPEAN JOURNAL OF CANCER
- Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM)
- (2017) M.J. Duffy et al. EUROPEAN JOURNAL OF CANCER
- Breast cancer
- (2017) Nadia Harbeck et al. LANCET
- HER2-positive breast cancer
- (2017) Sibylle Loibl et al. LANCET
- Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) José Baselga et al. LANCET ONCOLOGY
- HER2-positive breast cancer is lost in translation: time for patient-centered research
- (2017) Isabelle Gingras et al. Nature Reviews Clinical Oncology
- Endocrine Therapy in the Current Management of Postmenopausal Estrogen Receptor‐Positive Metastatic Breast Cancer
- (2017) Virginia G. Kaklamani et al. ONCOLOGIST
- Validated biomarkers: The key to precision treatment in patients with breast cancer
- (2016) Michael J. Duffy et al. BREAST
- Circulating tumor cells in breast cancer: applications in personalized medicine
- (2016) Jin Sun Lee et al. BREAST CANCER RESEARCH AND TREATMENT
- AZD9496: An Oral Estrogen Receptor Inhibitor That Blocks the Growth of ER-Positive and ESR1-Mutant Breast Tumors in Preclinical Models
- (2016) H. M. Weir et al. CANCER RESEARCH
- Tumor markers in the early detection of tumor recurrence in breast cancer patients: CA 125, CYFRA 21-1, HER2 shed antigen, LDH and CRP in combination with CEA and CA 15-3
- (2016) Dorit Di Gioia et al. CLINICA CHIMICA ACTA
- Mutation Analysis of Cell-Free DNA and Single Circulating Tumor Cells in Metastatic Breast Cancer Patients with High Circulating Tumor Cell Counts
- (2016) Jacqueline A. Shaw et al. CLINICAL CANCER RESEARCH
- Next Generation Sequencing of Circulating Cell-Free DNA for Evaluating Mutations and Gene Amplification in Metastatic Breast Cancer
- (2016) Karen Page et al. CLINICAL CHEMISTRY
- Serum Human Epidermal Growth Factor 2 Extracellular Domain as a Predictive Biomarker for Lapatinib Treatment Efficacy in Patients With Advanced Breast Cancer
- (2016) Chee Khoon Lee et al. JOURNAL OF CLINICAL ONCOLOGY
- PlasmaESR1Mutations and the Treatment of Estrogen Receptor–Positive Advanced Breast Cancer
- (2016) Charlotte Fribbens et al. JOURNAL OF CLINICAL ONCOLOGY
- Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline
- (2016) Lyndsay N. Harris et al. JOURNAL OF CLINICAL ONCOLOGY
- The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer
- (2016) James D Joseph et al. eLife
- The potential for liquid biopsies in the precision medical treatment of breast cancer
- (2016) Victoria A. Forte et al. Cancer Biology & Medicine
- Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2015) E. Senkus et al. ANNALS OF ONCOLOGY
- An individual reference limit for ‘early’ diagnosis of metastatic breast cancer during postoperative follow-up
- (2015) Andrea Nicolini et al. Biomarkers in Medicine
- Diagnostic efficacy of CA 15-3 and CEA in the early detection of metastatic breast cancer—A retrospective analysis of kinetics on 743 breast cancer patients
- (2015) Petra Stieber et al. CLINICA CHIMICA ACTA
- Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease
- (2015) Eleonor Olsson et al. EMBO Molecular Medicine
- Evaluation of the pharmacological activities of RAD1901, a selective estrogen receptor degrader
- (2015) Suzanne E Wardell et al. ENDOCRINE-RELATED CANCER
- Tumor Marker Usage and Medical Care Costs Among Older Early-Stage Breast Cancer Survivors
- (2015) Scott D. Ramsey et al. JOURNAL OF CLINICAL ONCOLOGY
- ESR1 mutations—a mechanism for acquired endocrine resistance in breast cancer
- (2015) Rinath Jeselsohn et al. Nature Reviews Clinical Oncology
- Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer
- (2015) Isaac Garcia-Murillas et al. Science Translational Medicine
- Analysis of ESR1 mutation in circulating tumor DNA demonstrates evolution during therapy for metastatic breast cancer
- (2015) Gaia Schiavon et al. Science Translational Medicine
- ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)
- (2014) F. Cardoso et al. BREAST
- Caution for interstitial lung disease as a cause of CA 15-3 rise in advanced breast cancer patients treated with everolimus
- (2014) Annelieke E.C.A.B. Willemsen et al. INTERNATIONAL JOURNAL OF CANCER
- Circulating Tumor Cells and Response to Chemotherapy in Metastatic Breast Cancer: SWOG S0500
- (2014) Jeffrey B. Smerage et al. JOURNAL OF CLINICAL ONCOLOGY
- Promoting Quality and Evidence-Based Care in Early-Stage Breast Cancer Follow-up
- (2014) L. N. Henry et al. JNCI-Journal of the National Cancer Institute
- Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data
- (2014) François-Clément Bidard et al. LANCET ONCOLOGY
- Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2013) R. Labianca et al. ANNALS OF ONCOLOGY
- Follow-up tests to detect recurrent disease: Patient's reassurance or medical need?
- (2013) Ian E. Smith et al. BREAST
- Use of imaging and biomarker tests for posttreatment care of early-stage breast cancer survivors
- (2013) Erin E. Hahn et al. CANCER
- Plastin3 Is a Novel Marker for Circulating Tumor Cells Undergoing the Epithelial-Mesenchymal Transition and Is Associated with Colorectal Cancer Prognosis
- (2013) T. Yokobori et al. CANCER RESEARCH
- Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update
- (2013) M.J. Duffy et al. INTERNATIONAL JOURNAL OF CANCER
- ESR1 ligand-binding domain mutations in hormone-resistant breast cancer
- (2013) Weiyi Toy et al. NATURE GENETICS
- Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
- (2013) Sarah-Jane Dawson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Circulating tumour cells in non-metastatic breast cancer: a prospective study
- (2012) Anthony Lucci et al. LANCET ONCOLOGY
- Detection of HER2 amplification in circulating free DNA in patients with breast cancer
- (2011) K Page et al. BRITISH JOURNAL OF CANCER
- HER2 shedding and serum HER2 extracellular domain: Biology and clinical utility in breast cancer
- (2011) Chantal Tsé et al. CANCER TREATMENT REVIEWS
- Vimentin in cancer and its potential as a molecular target for cancer therapy
- (2011) Arun Satelli et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Clinical significance of a serum CA 15-3 surge and the usefulness of CA 15-3 kinetics in monitoring chemotherapy response in patients with metastatic breast cancer
- (2010) Shih-Chung Wu et al. BREAST CANCER RESEARCH AND TREATMENT
- Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial
- (2010) Gordon JS Rustin et al. LANCET
- Serial determination of CEA and CA 15.3 in breast cancer follow-up: An assessment of their diagnostic accuracy for the detection of tumour recurrences
- (2009) Luigi Mariani et al. BIOMARKERS
- Clinical significance of a serum CA15-3 surge and the usefulness of CA15-3 kinetics in monitoring chemotherapy response in patients with metastatic breast cancer
- (2009) Hyo Song Kim et al. BREAST CANCER RESEARCH AND TREATMENT
- Serum HER-2/neuand relative resistance to trastuzumab-based therapy in patients with metastatic breast cancer
- (2008) Suhail M. Ali et al. CANCER
- National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers
- (2008) C. M. Sturgeon et al. CLINICAL CHEMISTRY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now